Reports Q2 revenue $3B, consensus $2.95B. “Over the first half of the year, DaVita has been focused on innovation in our clinical systems and driving operational improvements throughout our organization,” said Javier Rodriguez, CEO of DaVita Inc. “Our second quarter performance reflects strong traction across those initiatives, putting us on a path to deliver strong clinical outcomes and financial results for the year.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DVA: